Dai-ichi Life is Japan’s second-largest life insurance company excluding recently privatized Japan Post Insurance, with a market share of around 11% of annualized net premiums... Show more
DCNSF saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on June 25, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 29 instances where the indicator turned negative. In of the 29 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .
The 10-day RSI Indicator for DCNSF moved out of overbought territory on June 25, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 15 similar instances where the indicator moved out of overbought territory. In of the 15 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Momentum Indicator moved below the 0 level on June 25, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on DCNSF as a result. In of 32 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 69, placing this stock better than average.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.919) is normal, around the industry mean (1.496). P/E Ratio (14.144) is within average values for comparable stocks, (39.438). Projected Growth (PEG Ratio) (0.972) is also within normal values, averaging (0.675). Dividend Yield (0.032) settles around the average of (0.124) among similar stocks. P/S Ratio (0.323) is also within normal values, averaging (2.172).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. DCNSF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Industry LifeHealthInsurance
A.I.dvisor tells us that DCNSF and BHF have been poorly correlated (+3% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DCNSF and BHF's prices will move in lockstep.
Ticker / NAME | Correlation To DCNSF | 1D Price Change % | ||
---|---|---|---|---|
DCNSF | 100% | N/A | ||
BHF - DCNSF | 3% Poorly correlated | N/A | ||
PUK - DCNSF | 2% Poorly correlated | -0.20% | ||
LNC - DCNSF | -1% Poorly correlated | +0.29% | ||
AAIGF - DCNSF | -2% Poorly correlated | +5.98% | ||
FG - DCNSF | -2% Poorly correlated | -0.98% | ||
More |